This document is an excerpt from the EUR-Lex website
Document 62023CN0618
Case C-618/23, SALUS: Request for a preliminary ruling from the Oberlandesgericht Düsseldorf (Germany) lodged on 6 October 2023 — SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co. KG v Astrid Twardy GmbH
Case C-618/23, SALUS: Request for a preliminary ruling from the Oberlandesgericht Düsseldorf (Germany) lodged on 6 October 2023 — SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co. KG v Astrid Twardy GmbH
Case C-618/23, SALUS: Request for a preliminary ruling from the Oberlandesgericht Düsseldorf (Germany) lodged on 6 October 2023 — SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co. KG v Astrid Twardy GmbH
OJ C, C/2024/710, 22.1.2024, ELI: http://data.europa.eu/eli/C/2024/710/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Official Journal |
EN Series C |
C/2024/710 |
22.1.2024 |
Request for a preliminary ruling from the Oberlandesgericht Düsseldorf (Germany) lodged on 6 October 2023 — SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co. KG v Astrid Twardy GmbH
(Case C-618/23, SALUS)
(C/2024/710)
Language of the case: German
Referring court
Oberlandesgericht Düsseldorf
Parties to the main proceedings
Defendant and appellant: SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co. KG
Applicant and respondent: Astrid Twardy GmbH
Questions referred
1. |
Are herbal medicinal teas which are to be classified as ‘traditional herbal medicinal products’ within the meaning of point 29 of Article 1 and Article 16a of Directive 2001/83/EC, (1) inserted by points (1) and (2) of Article 1 of Directive 2004/24/EC, (2) (‘the Community code’) to be regarded as ‘plant-based traditional herbal preparations’ within the meaning of Article 2(1) of, in conjunction with Annex I to, Regulation (EU) 2018/848 (3) (‘the Regulation on organic production’ or ‘the Regulation’). |
2. |
If the first question is answered in the affirmative: Can the labelling provided for in Chapter IV of the Regulation, in particular
|
3. |
If the first or second question is answered in the negative: Is the labelling that is specified in the second question labelling that is ‘useful for the patient’ and is not ‘of a promotional nature’? |
(1) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67).
(2) Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use (OJ 2004 L 136, p. 85).
(3) Regulation (EU) 2018/848 of the European Parliament and of the Council of 30 May 2018 on organic production and labelling of organic products and repealing Council Regulation (EC) No 834/2007 (OJ 2018 L 150, p. 1).
ELI: http://data.europa.eu/eli/C/2024/710/oj
ISSN 1977-091X (electronic edition)